These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2424 related articles for article (PubMed ID: 12086261)

  • 1. Pathogenic mechanisms in giant cell arteritis.
    Weyand CM; Goronzy JJ
    Cleve Clin J Med; 2002; 69 Suppl 2():SII28-32. PubMed ID: 12086261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries.
    Borkowski A; Younge BR; Szweda L; Mock B; Björnsson J; Moeller K; Goronzy JJ; Weyand CM
    Am J Pathol; 2002 Jul; 161(1):115-23. PubMed ID: 12107096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis.
    Kaiser M; Weyand CM; Björnsson J; Goronzy JJ
    Arthritis Rheum; 1998 Apr; 41(4):623-33. PubMed ID: 9550471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of giant cell arteritis: More than just an inflammatory condition?
    Ly KH; Régent A; Tamby MC; Mouthon L
    Autoimmun Rev; 2010 Aug; 9(10):635-45. PubMed ID: 20457278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-destructive macrophages in giant cell arteritis.
    Rittner HL; Kaiser M; Brack A; Szweda LI; Goronzy JJ; Weyand CM
    Circ Res; 1999 May; 84(9):1050-8. PubMed ID: 10325242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis.
    Watanabe R; Maeda T; Zhang H; Berry GJ; Zeisbrich M; Brockett R; Greenstein AE; Tian L; Goronzy JJ; Weyand CM
    Circ Res; 2018 Aug; 123(6):700-715. PubMed ID: 29970365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathways in giant cell arteritis and polymyalgia rheumatica.
    Weyand CM; Ma-Krupa W; Goronzy JJ
    Autoimmun Rev; 2004 Jan; 3(1):46-53. PubMed ID: 14871649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic principles in giant cell arteritis.
    Weyand CM; Goronzy JJ
    Int J Cardiol; 2000 Aug; 75 Suppl 1():S9-S15; discussion S17-9. PubMed ID: 10980331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis.
    Zhang H; Watanabe R; Berry GJ; Vaglio A; Liao YJ; Warrington KJ; Goronzy JJ; Weyand CM
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E970-E979. PubMed ID: 28115719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of giant cell arteritis: new insight into the implication of CD161+ T cells.
    Samson M; Audia S; Martin L; Janikashvili N; Bonnotte B
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S65-73. PubMed ID: 23663684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis.
    Planas-Rigol E; Terrades-Garcia N; Corbera-Bellalta M; Lozano E; Alba MA; Segarra M; Espígol-Frigolé G; Prieto-González S; Hernández-Rodríguez J; Preciado S; Lavilla R; Cid MC
    Ann Rheum Dis; 2017 Sep; 76(9):1624-1634. PubMed ID: 28606962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis of primary large vessel arteritis].
    Arnaud L; Haroche J; Duhaut P; Piette JC; Amoura Z
    Rev Med Interne; 2009 Jul; 30(7):578-84. PubMed ID: 18804314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells.
    Kaiser M; Younge B; Björnsson J; Goronzy JJ; Weyand CM
    Am J Pathol; 1999 Sep; 155(3):765-74. PubMed ID: 10487834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Giant cell arteritis (temporal arteritis). Pathophysiology, immunology].
    Wagner AD
    Ophthalmologe; 2006 Apr; 103(4):302-7. PubMed ID: 16541271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis.
    Albano-Aluquin S; Malysz J; Kidacki M; Ratnam M; Olsen NJ
    J Vis Exp; 2019 Feb; (144):. PubMed ID: 30799840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune checkpoint dysfunction in large and medium vessel vasculitis.
    Watanabe R; Zhang H; Berry G; Goronzy JJ; Weyand CM
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H1052-H1059. PubMed ID: 28314758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis.
    Weyand CM; Wagner AD; Björnsson J; Goronzy JJ
    J Clin Invest; 1996 Oct; 98(7):1642-9. PubMed ID: 8833914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease.
    Weyand CM; Berry GJ; Goronzy JJ
    J Leukoc Biol; 2018 Mar; 103(3):565-575. PubMed ID: 28848042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiology and pathophysiology of giant cell arteritis].
    Greigert H; Bonnotte B; Samson M
    Rev Prat; 2023 Apr; 73(4):380-386. PubMed ID: 37289150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiology of giant cell arteritis].
    Ly KH; Liozon E; Fauchais AL; Vidal E
    Rev Med Interne; 2013 Jul; 34(7):392-402. PubMed ID: 23528439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 122.